| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 29,8 k € | -3.9% | 31,0 k € | +0.1% | 31,0 k € | +8.1% | 28,6 k € | -10.3% | 31,9 k € | +1.2% | 31,5 k € | +22.5% | 25,8 k € | +597.4% | 3,7 k € | -32.2% | 5,4 k € | +13.6% | 4,8 k € | -85.4% | 32,9 k € | -43.9% | 58,6 k € | -37.2% | 93,2 k € | +0.2% | 93,0 k € | +23.4% | 75,4 k € | +31.2% | 57,5 k € | -46.6% | 107,6 k € | +58.6% | 67,8 k € | +274.8% | 18,1 k € | |
| EBITDA | 29,3 k € | -4.0% | 30,5 k € | +0.1% | 30,5 k € | +8.1% | 28,2 k € | -10.4% | 31,5 k € | +1.2% | 31,1 k € | +22.9% | 25,3 k € | +671.9% | 3,3 k € | -34.9% | 5,0 k € | +14.9% | 4,4 k € | -86.5% | 32,4 k € | -44.2% | 58,2 k € | -37.3% | 92,8 k € | +0.2% | 92,6 k € | +23.5% | 75,0 k € | +31.4% | 57,0 k € | -46.8% | 107,2 k € | +58.0% | 67,8 k € | +274.8% | 18,1 k € | |
| Operating profit | 29,3 k € | -4.0% | 30,5 k € | +0.1% | 30,5 k € | +8.1% | 28,2 k € | -10.4% | 31,5 k € | +1.2% | 31,1 k € | +22.9% | 25,3 k € | +671.9% | 3,3 k € | -34.9% | 5,0 k € | +14.9% | 4,4 k € | -86.5% | 32,4 k € | -44.2% | 58,2 k € | -37.3% | 92,8 k € | +0.2% | 92,6 k € | +23.5% | 75,0 k € | +31.4% | 57,0 k € | -46.8% | 107,2 k € | +58.0% | 67,8 k € | +274.8% | 18,1 k € | |
| Profit/loss | 8,1 k € | -31.1% | 11,8 k € | -28.0% | 16,4 k € | +14.8% | 14,3 k € | -12.6% | 16,4 k € | +9.0% | 15,0 k € | +6.2% | 14,1 k € | +1008.0% | -1,6 k € | -147.5% | 3,3 k € | +156.8% | -5,8 k € | -129.4% | 19,6 k € | -46.0% | 36,3 k € | -24.4% | 48,1 k € | -26.4% | 65,3 k € | +33.2% | 49,0 k € | +27.0% | 38,6 k € | +285.8% | 10,0 k € | -83.9% | 62,0 k € | +713.0% | 7,6 k € | |
| Equity | 145,2 k € | -42.2% | 251,2 k € | +4.9% | 239,4 k € | +7.4% | 222,9 k € | +6.9% | 208,6 k € | +8.5% | 192,3 k € | +8.5% | 177,3 k € | +8.7% | 163,2 k € | -58.5% | 392,7 k € | +0.8% | 389,4 k € | -1.5% | 395,2 k € | +5.2% | 375,6 k € | +3.0% | 364,6 k € | +15.2% | 316,5 k € | +26.0% | 251,2 k € | +24.3% | 202,1 k € | +23.6% | 163,6 k € | +6.5% | 153,6 k € | +67.7% | 91,5 k € | |
| Total assets | 434,7 k € | +1.1% | 430,1 k € | +3.0% | 417,5 k € | +0.7% | 414,4 k € | +0.8% | 411,1 k € | +1.0% | 406,9 k € | -1.3% | 412,2 k € | +3.9% | 396,7 k € | +0.4% | 395,1 k € | +0.1% | 394,9 k € | -4.8% | 414,9 k € | -0.7% | 418,0 k € | -0.7% | 420,9 k € | -0.0% | 420,9 k € | +3.9% | 405,2 k € | -9.6% | 448,1 k € | -0.8% | 451,8 k € | +14.2% | 395,5 k € | -2.0% | 403,8 k € | |
| Cash | 7,8 k € | +956.6% | 736,4 € | -89.3% | 6,9 k € | -19.2% | 8,5 k € | -21.5% | 10,9 k € | +8.7% | 10,0 k € | -26.0% | 13,5 k € | +99.1% | 6,8 k € | +29.7% | 5,2 k € | +27.9% | 4,1 k € | -0.7% | 4,1 k € | +2.4% | 4,0 k € | -67.9% | 12,5 k € | -0.0% | 12,6 k € | +91.7% | 6,5 k € | -7.0% | 7,0 k € | +6.3% | 6,6 k € | +1646.1% | 379,1 € | -35.1% | 584,1 € | |
| Debts | 287,1 k € | +61.1% | 178,2 k € | +0.0% | 178,1 k € | -7.0% | 191,4 k € | -5.5% | 202,5 k € | -5.7% | 214,6 k € | -8.6% | 234,9 k € | +0.6% | 233,5 k € | +9517.0% | 2,4 k € | -55.6% | 5,5 k € | -72.2% | 19,7 k € | -53.6% | 42,4 k € | -24.7% | 56,3 k € | -46.0% | 104,4 k € | -32.2% | 154,1 k € | -37.4% | 245,9 k € | -14.7% | 288,2 k € | +19.1% | 242,0 k € | -22.5% | 312,2 k € | |
Public limited company · Hamont-Achel · incorporated on 09/03/1999
Public limited company profitable and well capitalised. Cash position rising (+956.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PMS MEDICAL is a Public limited company incorporated in 1999. Its main activity is: Activities of holding companies. Its registered office is in Hamont-Achel.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette